Skip To Content

News & Events

Given the activity level of our attorneys, we are confident in showcasing the various matters that our clients have given us the privilege to work on and approved to post here.

Posts

  • November 26 2019

    Viveve Medical Inc. announced the closing of their Underwritten offering in the amount of $10,469,997.  EG&S acted as counsel to the Underwriter.

  • November 22 2019

    IeMagin Corporation announced the closing of their At the Market offering in the amount of $1,700,000.  EG&S acted as counsel to the Placement Agent.

  • November 22 2019

    Genprex Inc. announced the closing of their Registered Direct offering in the amount of $1,267,194.  EG&S acted as counsel to the Placement Agent.

  • November 22 2019

    McEwen Mining, Inc. announced the closing of their Underwritten offering in the amount of $50,019,316.  EG&S acted as counsel to the Underwriter.

  • November 19 2019

    Yeild10 Bioscience, Inc. announced the closing of their Underwritten offering in the amount of $4,999,750.  EG&S acted as counsel to the Underwriter.

  • November 18 2019

    Lipocine Inc. announced the closing of their Registered Direct offering in the amount of $6,000,000.  EG&S acted as counsel to the Placement Agent.

  • November 15 2019

    EGS represented a family office in the sale of one of its portfolio company to a public company for $120 million in cash.

  • November 15 2019

    Diffusion Pharmaceuticals Inc. announced the closing of their S-1 offering in the amount of $4,000,000.  EG&S acted as counsel to the Placement Agent.

“It’s with genuine appreciation to all of our clients that we are in a position to achieve and maintain our leadership position in so many areas.”